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Despite the improvement in mental health care that has
occurred in the last decades, the mortality risk in
patients with schizophrenia has not been changed, and
there was even an increase in the mortality of these
patients when compared to the general population. The
main causes for this increased mortality are somatic dis-
eases, especially diabetes, hypercholesterolemia, hyper-
trygliceridemia, cardiovascular diseases (including
arterial hypertension), obesity, HIV infection/AIDS,
hepatitis C and osteoporosis [1]. The link between sec-
ond generation antipsychotics and cardiovascular risk
factors has raised questions on their overall safety, and
these concerns are even more important if patients are
on compulsory treatment. Furthermore, at least half of
patients suffering from schizophrenia have one co-
morbidity not diagnosed or wrongly diagnosed [2]. In a
s a m p l eo f4 7 6c o m m u n i t yp a t i e n t ss u f f e r i n gf r o ms c h i -
zophrenia, we found rates of diagnosed hypertension of
6,9%, hypercholesterolemia of 9,0%, hypertrigliceridemia
of 6,3%, and diabetes of 4,2%. Not only these figures are
lower than in other large studies, but also apparently
only 12 to 30% of the patients presenting these disorders
were being treated for these conditions [3]. Barriers to
recognition and management of physical diseases in
patients with schizophrenia are related both to health
care providers and to patient/disease. Acute admission
could be a target for the screening and treatment of
these disorders, and we tried to find a screening proto-
col for this situation. Acutely ill patients have higher
rates of infections and liver abnormalities, but lower
rates of hypercholesterolemia [4]. In our sample more
than 80% of patients with schizophrenia are retired or
unemployed. Resources are scarce, and their allocation
to these patients can prevent the access of people suffer-
ing from other disorders to the care they need.
Published: 22 April 2010
References
1. Saha S, et al: A systematic review of mortality in schizophrenia: is the
differential mortality gap worsening over time? Arch Gen Psychiatry 2007,
64(10):1123-31.
2. Muir-Cochrane E: Medical co-morbidity risk factors and barriers to care
for people with schizophrenia. Journal of psychiatric and mental health
nursing 2006, 13(4):447-52.
3. Simões do Couto F, et al: The characterization of a Portuguese
population of outpatients with schizophrenia, and their therapeutical
management, in the European context..
4. Teixeira J, et al: Which blood analysis should be requested to patients
with schizophrenia when hospitalized for acute psychosis? 17th EPA
European Congress of Psychiatry, Lisbon, January 24-28, 2009 .
doi:10.1186/1744-859X-9-S1-S74
Cite this article as: do Couto: Medical care and long-term treatment of
patients with schizophrenia: ethical concerns. Annals of General Psychiatry
2010 9(Suppl 1):S74.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Neuroscience Department of the Institute of Molecular Medicine, Lisbon,
and Department of Psychiatry, Hospital de Santa Maria and Faculty of
Medicine of Lisbon, Portugal
do Couto Annals of General Psychiatry 2010, 9(Suppl 1):S74
http://www.annals-general-psychiatry.com/content/9/S1/S74
© 2009 do Couto; licensee BioMed Central Ltd.